Gene · 9966
Papers2,280
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,280
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emotional social screening tool for school readiness (E3SR-R): Adaptation into Afrikaans. | Afr J Psychol Assess | 2025 | 40474877 | PubTator, text mining | PubMed |
Building on the Translational Science Benefits Model to include team science: a practical and theory-based approach to continuous quality improvement and impact evaluation for Clinical and Translational Science Award programs. | Front Public Health | 2025 | 40458088 | PubTator, text mining | PubMed |
| Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial. | Lancet Gastroenterol Hepatol | 2025 | 40456235 | PubTator, text mining | PubMed |
| Translational Regulation of Plant Stress Responses: Mechanisms, Pathways, and Applications in Bioengineering. | Annu Rev Phytopathol | 2025 | 40455831 | PubTator, text mining | PubMed |
| A hydrophobic loop of the spider-venom peptide Tl1a drives activity at NaV1.8. | Eur J Pharmacol | 2025 | 40414593 | PubTator, text mining | PubMed |
| The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer. | Front Med (Lausanne) | 2025 | 40370720 | PubTator, text mining | PubMed |
| Collagen (rs3134646) and ARHGAP15 (rs4662344) genetic variants may predispose to colonic diverticulosis. | Adv Med Sci | 2025 | 40274021 | PubTator, text mining | PubMed |
| Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis. | J Immunol | 2025 | 40127640 | PubTator, text mining | PubMed |
| [Intestinal fibrosis in Crohn's disease : towards new therapeutic options?] | Rev Med Liege | 2025 | 40079288 | PubTator, text mining | PubMed |
| Transmission line faults detection and classification using new tripping characteristics based on statistical coherence for current measurements. | Sci Rep | 2025 | 40074740 | PubTator, text mining | PubMed |
| Japanese Phase 1 Study for Global Development of Anti-TL1A Antibody PF-06480605: A Randomized, Placebo-Controlled, Single-Ascending Dose Study. | Clin Transl Sci | 2025 | 40065559 | PubTator, text mining | PubMed |
| Linc00205/Mir-495-3p/Tnfsf15 Axis is Implicated in the Treatment Effect of Hyperbaric Oxygen Therapy on Patients with Post-Stroke Cognitive Impairment. | Noro Psikiyatr Ars | 2025 | 40046208 | PubTator, text mining | PubMed |
| Subtype cluster analysis unveiled the correlation between m6A- and cuproptosis-related lncRNAs and the prognosis, immune microenvironment, and treatment sensitivity of esophageal cancer. | Front Immunol | 2025 | 40034693 | PubTator, text mining | PubMed |
| TL1A, a novel alarmin in airway, intestinal, and autoimmune disorders. | J Allergy Clin Immunol | 2025 | 40010414 | PubTator, text mining | PubMed |
| Drug Development in Inflammatory Bowel Diseases: What Is Next? | Pharmaceuticals (Basel) | 2025 | 40006003 | PubTator, text mining | PubMed |
| TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review. | BioDrugs | 2025 | 39907869 | PubTator, text mining | PubMed |
| Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues ameliorating GVHD post-HSCT. | bioRxiv | 2025 | 39896683 | PubTator, text mining | PubMed |
| Urine proteomics defines an immune checkpoint-associated nephritis signature. | J Immunother Cancer | 2025 | 39863302 | PubTator, text mining | PubMed |
| The TL1A inhibitors in IBD: what's in the pot? | Expert Rev Gastroenterol Hepatol | 2025 | 39772947 | PubTator, text mining | PubMed |
| Functionalized aluminum hydroxide-based self-adjuvanted nanovaccine orchestrates antitumor immune responses via Dectin-1 signaling. | J Control Release | 2025 | 39716663 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9966/papers?page=6